Filter
2222
Filtered Results: 2222
Text search:
drug-resistant
TB
Featured
Recommendations
222
New Publications
621
Language
Document type
No document type
1433
Studies & Reports
272
Guidelines
249
Manuals
78
Strategic & Response Plan
68
Situation Updates
43
Fact sheets
35
Training Material
29
Infographics
8
Brochures
3
Online Courses
3
Videos
1
Countries / Regions
India
127
Kenya
72
South Africa
72
Western and Central Europe
71
Eastern Europe
50
Nepal
49
Global
49
Tanzania
47
Ethiopia
46
Uganda
40
Zambia
39
Namibia
37
Nigeria
36
Malawi
32
Myanmar / Burma
31
Ghana
30
Sierra Leone
30
Liberia
30
Latin America and the Carribbean
27
Bangladesh
27
Rwanda
26
Africa
26
Lesotho
24
Cambodia
23
Asia
23
Ukraine
20
Philippines
18
South–East Asia Region
16
Zimbabwe
15
Indonesia
15
Russia
14
Botswana
14
Colombia
12
Senegal
12
Mozambique
11
Eswatini/ Swaziland
9
Pakistan
9
Tajikistan
8
Germany
8
Argentina
8
Cameroon
7
Albania
7
Haiti
7
Venezuela
7
Congo, Democratic Republic of
7
Burkina Faso
6
Thailand
5
El Salvador
5
Peru
5
Armenia
5
West and Central Africa
5
East and Southern Africa
5
Brazil
5
Georgia
5
Syria
4
Laos
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Paraguay
4
Vietnam
4
Sudan
4
South Sudan
4
North Macedonia
3
Timor Leste/ East Timor
3
Benin
3
Estonia
3
Guinea
3
Western Pacific Region
3
Uruguay
3
Bolivia
3
Moldova
3
Sri Lanka
3
Iran
2
Afghanistan
2
Morocco
2
USA
2
Jordan
2
Lebanon
2
Papua New Guinea
2
Nicaragua
2
Romania
2
Honduras
2
Bhutan
2
Ecuador
2
Madagascar
2
Guatemala
2
North Korea
1
Switzerland
1
Mexico
1
Gambia
1
China
1
Chile
1
Bulgaria
1
Dominican Republic
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
North America
1
Gabon
1
Turkmenistan
1
Maldives
1
Tunisia
1
Spain
1
Belize
1
Costa Rica
1
Panama
1
Yemen
1
Greece
1
Central African Republic
1
Poland
1
Angola
1
Iraq
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
916
Clinical Guidelines
190
Public Health
67
Women & Child Health
40
Key Resources
38
Capacity Building
29
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
TB
666
HIV
287
AMR
183
Pharmacy
49
NTDs
45
COVID-19
37
Caregiver
29
Ebola & Marburg
28
Refugee
24
Global Health Education
23
Mental Health
20
Polio
19
Conflict
18
Health Financing Toolbox
17
Rapid Response
16
Planetary Health
15
NCDs
14
Malaria
13
Disability
6
Natural Hazards
5
Cholera
3
Specific Hazards
2
Social Ethics
2
Zika
1
This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review,
product development landscape, and stakeholder interviews was compiled to:
- Identify use cases and understand current diagnosti...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The guidelines acknowledge that overcrowding, unhygienic conditions and high inmate turn over contribute to the spread of infectious diseases within correctional facilities. The document states that voluntary HIV counselling and testing must be offered to all inmates when they enter facilities, duri...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Guidelines for the Prevention of Tuberculosis in Health Care Facilities in Resource-limited Settings
These guidelines are designed for settings with limited resources to provide inexpensive and effective control strategies for prevention of TB transmission in health care workers (HCW).
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
This handbook builds on lessons learned from surveys implemented 2015-2017 and advice provided by the Global task force on TB patient cost surveys. It provides a standardized methodology for conducting health facility-based cross-sectional surveys to assess the direct and indirect costs incurred by ...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Este documento presenta modelos de algoritmos que permiten investigar por métodos bacteriológicos a los pacientes para el diagnóstico de tuberculosis (TB), TB asociada al Virus de Inmunodeficiencia Humana (TB-HIV) y TB drogorresistente (TBDR).
Acta Med Peru. 2017;34(3):182-7; El objetivo del presente trabajo es conocer la magnitud del problema de la TB y sus principales características epidemiológicas en la población del penal de varones de penal de varones de Trujillo, que sirva de base para plantear las mejores soluciones terapéutic...
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop TB disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s im...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
Expert Consensus Validation 2018.
This innovative approach aimed at improving and facilitating the screening, prescribing and monitoring of drug therapy for older patients, is currently being further developed in the area of Clinical Pharmacology at the University of Heidelberg in Mannheim. This ap...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support ...
Primary Care 101
recommended
Symptom-based integrated approach to the adult in primary care.
Primary Care 101 is a comprehensive clinical practice guideline that aims to equip nurses and other clinicians to diagnose and manage common adult conditions at primary level.
Tb; HIV; Asthma/COPD; cardiovascular disease; diabetes; M...
